{"title":"鼻窦炎引起的格林-巴利综合征","authors":"O. Ungar, Anat Wangier, N. Omer, I. Koren","doi":"10.17352/2455-1759.000081","DOIUrl":null,"url":null,"abstract":"Guillain-Barre syndrome (GBS) is a heterogeneous, \nrelatively uncommon, post-infectious, immune-mediated \npolyradiculoneuropathy. It is estimated to affect 1.1- \n1.8/100,000/year in Europe and North America [1]. Historically, \nGBS was considered to be a single disorder, but it is currently \nclassifi ed into six clinically distinct subtypes.","PeriodicalId":440305,"journal":{"name":"Archives of Otolaryngology and Rhinology","volume":"70 3","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sinusitis-Induced Guillain-Barré Syndrome\",\"authors\":\"O. Ungar, Anat Wangier, N. Omer, I. Koren\",\"doi\":\"10.17352/2455-1759.000081\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Guillain-Barre syndrome (GBS) is a heterogeneous, \\nrelatively uncommon, post-infectious, immune-mediated \\npolyradiculoneuropathy. It is estimated to affect 1.1- \\n1.8/100,000/year in Europe and North America [1]. Historically, \\nGBS was considered to be a single disorder, but it is currently \\nclassifi ed into six clinically distinct subtypes.\",\"PeriodicalId\":440305,\"journal\":{\"name\":\"Archives of Otolaryngology and Rhinology\",\"volume\":\"70 3\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Otolaryngology and Rhinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17352/2455-1759.000081\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Otolaryngology and Rhinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/2455-1759.000081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Guillain-Barre syndrome (GBS) is a heterogeneous,
relatively uncommon, post-infectious, immune-mediated
polyradiculoneuropathy. It is estimated to affect 1.1-
1.8/100,000/year in Europe and North America [1]. Historically,
GBS was considered to be a single disorder, but it is currently
classifi ed into six clinically distinct subtypes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
